12/4 Biosimilars Webinar: Perspectives on Biosimilars


Posted on November 19th, by Michael Shapiro-Barr

Join the Drinker Biddle Life Sciences Team for a webinar panel discussion on the development of Biosimilars in the United States and abroad. The panel will discuss an overview of regulatory issues, perspectives from the IP community, and practical advice in this rapidly developing area of the pharmaceutical industry, including:

  • FDA regulations and recently published draft guidance documents
  • Biosimilars activity abroad and how it may inform the US regulatory pathway
  • Strategies for pursuing the Biosimilars pathway
  • Preparing for Biosimilars litigation
  • Overcoming hurdles in Biosimilars development

This complimentary presentation is intended for both in-house and outside pharmaceutical counsel and patent attorneys.

Tuesday, December 4, 2012
1 – 2:30 p.m. Eastern

Moderator:

John Jay Marshall
Of Counsel, Intellectual Property
Drinker Biddle & Reath

Speakers:

Christine Norris
Associate, Intellectual Property
Drinker Biddle & Reath

Debora Plehn-Dujowich, Ph.D
Associate, Intellectual Property
Drinker Biddle & Reath

Doyle Siever, Ph.D
Intellectual Property Attorney
Intrexon Corporation

To register for the webinar, please click here.





Comments are closed.



From the Blog

Where to Spend Your Healthcare Investment Dollars

In a blog entry written over the summer, I expressed the view that the next 5-10 years will present tremendous transactional opportunities in the life...

Second Circuit Rejects Government’s Off-Label Enforcement Approach

Last week’s decision in the off-label promotion case, United States v. Caronia, No. 09-5006-cr (2d Cir. Dec. 3, 2012), is an important blow to...

Massachusetts Refines Its Sunshine Law; Final Federal Sunshine Regulations Moving Ahead

The relationship between health care providers and drug and device manufacturers has been a focus of lawmakers at both the federal and state level. ...

Subscribe by Email for New Blog Posts